NMN vs NR for NAD Boosting: What the Evidence Actually Shows
Both NMN and NR raise NAD+ levels in humans, but clinical proof of anti-aging benefits is still lacking — and product quality varies widely.
141 articles
Both NMN and NR raise NAD+ levels in humans, but clinical proof of anti-aging benefits is still lacking — and product quality varies widely.
A new review maps the structural and functional changes that help the bowel compensate after resection, and highlights where knowledge gaps remain.
A landmark review reveals how sustained glucocorticoid exposure drives aging biology — and what can be done about it.
A landmark review reframes astrocytes as multilayered processing units that regulate synapses, circuits, and brain function at multiple spatial scales.
A landmark review reveals how diet, gut bacteria, and their metabolites determine the success of immune checkpoint blockade cancer therapy.
A Lancet review reveals stroke pathways fail to adequately address frailty, disability, and comorbidity — gaps with major consequences for older patients.
A new framework warns that AI tools used too early in medical education may prevent trainees from developing core clinical reasoning skills.
A candid breakdown of top NAD+ booster brands reveals strong biomarker data but slim evidence for real longevity outcomes.
A new framework redefines age-related insulin resistance as a systemic collapse of metabolic resilience spanning muscle, fat, brain, and more.
A major review in Nature Medicine explores how CAR cell therapies may achieve deep immune 'reset' in autoimmune diseases by depleting pathogenic B cells.
Aging disrupts gut microbiota and mTOR signaling, crippling vaccine responses — but targeted interventions may reverse this.
A 2026 comparative review of leading NAD+ supplements reveals NR has stronger human data, while NMN marketing often outpaces clinical proof.